The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
暂无分享,去创建一个
E. Giné | A. López-Guillermo | E. Campo | P. Jares | F. Prósper | X. Puente | S. Beà | J. Martín-Subero | T. Baumann | R. Beekman | G. Castellano | G. Clot | J. Delgado | A. Queirós | R. Royo | C. López-Otín | X. Agirre | M. Kulis | C. Oakes | T. Zenz | R. Ordoñez | Junyan Lu | J. Wiemels | C. Oakes | Montserrat Puiggrós | J. Nordlund | G. Lönnerholm | M. Duran-Ferrer | Seung-Tae Lee | F. Nadeu | Silvia Martín | Y. Marincevic-Zuniga | A. Rivas-Delgado | L. Seung-Tae | Yanara Marincevic-Zuniga | Lee Seung-Tae | Montserrat Puiggròs
[1] A. Tanay,et al. Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells , 2020, Nature Genetics.
[2] E. Giné,et al. Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. , 2020, Blood.
[3] S. Horvath,et al. DNA methylation aging clocks: challenges and recommendations , 2019, Genome Biology.
[4] Julio Delgado,et al. The U1 spliceosomal RNA is recurrently mutated in multiple cancers , 2019, Nature.
[5] Romina Royo,et al. A practical guide for mutational signature analysis in hematological malignancies , 2019, Nature Communications.
[6] T. Phillips. Challenges and recommendations , 2019, Forests and Water.
[7] Martin J. Aryee,et al. Epigenetic evolution and lineage histories of chronic lymphocytic leukemia , 2019, Nature.
[8] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[9] J. Ecker,et al. Dynamic DNA methylation: In the right place at the right time , 2018, Science.
[10] J. Martín-Subero,et al. Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies. , 2018, Blood.
[11] Trey Ideker,et al. DNA Methylation Clocks in Aging: Categories, Causes, and Consequences. , 2018, Molecular cell.
[12] J. Carroll,et al. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation , 2018, Nucleic acids research.
[13] F. Lasitschka,et al. Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis. , 2018, Cell reports.
[14] R. Guigó,et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia , 2018, Nature Medicine.
[15] Stefano Monti,et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.
[16] Roland Schmitz,et al. Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.
[17] Steve Horvath,et al. DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.
[18] Peter W. Laird,et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer , 2018, Cell.
[19] K. Schmiegelow,et al. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia , 2018, Clinical Epigenetics.
[20] Andrew E. Teschendorff,et al. Statistical and integrative system-level analysis of DNA methylation data , 2017, Nature Reviews Genetics.
[21] B. Brors,et al. Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin , 2018, Nature Communications.
[22] Ahrim Youn,et al. The MiAge Calculator: a DNA methylation-based mitotic age calculator of human tissue types , 2018, Epigenetics.
[23] Hui Shen,et al. DNA methylation loss in late-replicating domains is linked to mitotic cell division , 2018, Nature Genetics.
[24] C. Plass,et al. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib , 2018, International journal of cancer.
[25] Andrzej K. Oleś,et al. Supplementary figures and tables , 2017 .
[26] L. Staudt,et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets , 2016, Leukemia.
[27] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[28] W. Wilson,et al. Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier , 2017, Haematologica.
[29] R. Hawley,et al. Increased expression of the tight junction protein TJP1/ZO-1 is associated with upregulation of TAZ-TEAD activity and an adult tissue stem cell signature in carfilzomib-resistant multiple myeloma cells and high-risk multiple myeloma patients , 2017, Oncoscience.
[30] A. Ferrari,et al. Front‐line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group , 2017, Pediatric blood & cancer.
[31] R. Siebert,et al. DNA methylation profiling of pediatric B‐cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites , 2017, Pediatric blood & cancer.
[32] R. Wilson,et al. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression , 2017, Cell.
[33] Steven J. M. Jones,et al. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery , 2016, Cell.
[34] E. Giné,et al. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage. , 2016, Cancer cell.
[35] Shijie C. Zheng,et al. Correlation of an epigenetic mitotic clock with cancer risk , 2016, Genome Biology.
[36] J. Byrd,et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.
[37] E. Ballestar,et al. IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation , 2016, Genome Biology.
[38] M. Hebrok,et al. Regulation of Cellular Identity in Cancer. , 2015, Developmental cell.
[39] Andrew P. Feinberg,et al. DNA methylation is stable during replication and cell cycle arrest , 2015, Scientific Reports.
[40] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[41] K. Tarte,et al. Cell-Cycle-Dependent Reconfiguration of the DNA Methylome during Terminal Differentiation of Human B Cells into Plasma Cells. , 2015, Cell reports.
[42] Roland Eils,et al. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control , 2015, Nature Genetics.
[43] Martin A. Nowak,et al. Mutations driving CLL and their evolution in progression and relapse , 2015, Nature.
[44] S. Cockell,et al. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia , 2015, Epigenetics.
[45] A. Valencia,et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia , 2015, Nature.
[46] Mikael Sigvardsson,et al. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. , 2015, Blood.
[47] Ronald P. Schuyler,et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.
[48] Valer Gotea,et al. Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype , 2015, Epigenetics & Chromatin.
[49] Paul Flicek,et al. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers , 2015, Genome research.
[50] Luc André,et al. CORRIGENDUM: Landscape cultivation alters δ30Si signature in terrestrial ecosystems , 2015, Scientific Reports.
[51] S. Heath,et al. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures , 2015, Nucleic acids research.
[52] M. J. You,et al. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment. , 2015, Blood.
[53] Sandra Macedo-Ribeiro,et al. Structure of mycobacterial maltokinase, the missing link in the essential GlgE-pathway , 2015, Scientific Reports.
[54] W. Reik,et al. Selective impairment of methylation maintenance is the major cause of DNA methylation reprogramming in the early embryo , 2015, Epigenetics & Chromatin.
[55] Hong Liu,et al. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance. , 2014, International journal of oncology.
[56] E. Giné,et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact , 2014, Leukemia.
[57] R. Gascoyne,et al. The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.
[58] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[59] Christopher R. Schmidt,et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. , 2014, Cancer discovery.
[60] D. Colomer,et al. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma , 2013, Cell Death and Differentiation.
[61] Alfonso Valencia,et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia , 2014, Genome research.
[62] A. Eychène,et al. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target , 2014, Blood Cancer Journal.
[63] A. Eychène,et al. GSK 3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target , 2014 .
[64] S. Horvath. DNA methylation age of human tissues and cell types , 2013, Genome Biology.
[65] Christofer L. Bäcklin,et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia , 2013, Genome Biology.
[66] A. Gnirke,et al. Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.
[67] G. Morgan,et al. Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. , 2013, Blood.
[68] Michael B. Stadler,et al. Identification of active regulatory regions from DNA methylation data , 2013, Nucleic acids research.
[69] Zachary D. Smith,et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. , 2013, Cell stem cell.
[70] M. Esteller,et al. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia , 2012, British journal of haematology.
[71] Alfonso Valencia,et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.
[72] Zohar Mukamel,et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues , 2012, Nature Genetics.
[73] E. Giné,et al. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. , 2012, Cancer research.
[74] J. Kere,et al. Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility , 2012, PloS one.
[75] A. Oshlack,et al. SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.
[76] Devin C. Koestler,et al. DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.
[77] Erik van Nimwegen,et al. Corrigendum: DNA-binding factors shape the mouse methylome at distal regulatory regions , 2012, Nature.
[78] T. Bosch,et al. DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells , 2012, Angiogenesis.
[79] Manolis Kellis,et al. ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.
[80] P. Laird,et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.
[81] Vijay K. Tiwari,et al. DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.
[82] Klaus Kayser,et al. To be at the right place at the right time , 2011, Diagnostic pathology.
[83] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[84] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[85] D. Aran,et al. Replication timing-related and gene body-specific methylation of active human genes. , 2011, Human molecular genetics.
[86] O. Elemento,et al. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. , 2010, Blood.
[87] P. Sonneveld,et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. , 2010, Blood.
[88] M. Jourdan,et al. Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation , 2010, Leukemia.
[89] Owen T McCann,et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. , 2010, Genome research.
[90] Wolfgang Wagner,et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.
[91] Lee E. Edsall,et al. Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.
[92] Paul Marjoram,et al. Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers , 2009, Proceedings of the National Academy of Sciences.
[93] Samir Ouchani,et al. Gene Selection for Cancer Classification Using DCA , 2008, ADMA.
[94] R. Spang,et al. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia , 2007, Leukemia.
[95] Zohar Yakhini,et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.
[96] P. Laird,et al. Epigenetic stem cell signature in cancer , 2007, Nature Genetics.
[97] Kelly M. McGarvey,et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.
[98] M. Fraga,et al. The Polycomb group protein EZH2 directly controls DNA methylation , 2006, Nature.
[99] J. Issa. CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.
[100] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[101] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[102] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.